Schlenk, R. F. (2024) “Genetics as predictive marker for consolidation therapy with high-dose cytarabine in acute myeloid leukemia”, Haematologica. Pavia, Italy, 109(6), pp. 1629-1630. doi: 10.3324/haematol.2024.285624.